P 1.02:
Population Balance Modeling of Cooling-Antisolvent Crystallization to Derisk Tech-Transfer
Dr. Tamar Rosenbaum | Bristol-Myers Squibb | United States
Show details
Authors:
Dr. Tamar Rosenbaum | Bristol-Myers Squibb | United States
Li Tan | Bristol-Myers Squibb | United States
Dr. Niall Mitchell | Process Systems Enterprise Limited, London | United Kingdom
Michael Dummeldinger | Bristol-Myers Squibb | United States
Joshua Engstrom | Bristol-Myers Squibb | United States
P 1.05:
Batch crystallization of xylitol by cooling, evaporation and anti-solvent addition
Anna Zaykovskaya | Aalto University School of Chemical Engineering | Finland
Show details
Authors:
Anna Zaykovskaya | Aalto University School of Chemical Engineering | Finland
Dr. Erik Temmel | Sulzer Chemtech Ltd | Switzerland
Dr. Manfred Stepanski | Sulzer Chemtech Ltd | Switzerland
Baudine Gevers Deynoot | Avantium | Netherlands
Edserd de Jong | Avantium | Netherlands
Prof. Marjatta Louhi-Kultanen | Aalto University | Finland
P 1.09:
Bullet-Proofing Doravirine (MK-1439) Starting Material Supply: Rapid Identification and Response to a New Polymorph of Ethyl Ester
Dr. Patrick Larpent | MSD Werthenstein BioPharma | Switzerland
Show details
Authors:
Dr. Patrick Larpent | MSD Werthenstein BioPharma | Switzerland
Lorenzo Codan | MSD Werthenstein BioPharma | Switzerland
Dr. Jochen Schoell | MSD Werthenstein BioPharma | Switzerland
Luca Iuzzolino | Merck & Co. Inc. | United States
Melissa Tan | Merck & Co. Inc. | United States
Justin A. Newman | Merck & Co. Inc. | United States
Alfred Y. Lee | Merck & Co. Inc. | United States